GCT and EOC patients had the strongest CLDN6 expression, with an average of >80% tumor cells with 2+/3+ (intermediate/strong) staining intensity (Fig. 1d and Supplementary Fig. 1). This evidence concerns the gene CLDN6 and granular cell tumor.